Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-CD38 monoclonal antibody SCTC21C

A monoclonal antibody that targets the cell surface glycoprotein CD38, with potential antineoplastic activity. Upon administration, anti-CD38 monoclonal antibody SCTC21C targets and binds to CD38 on CD38-positive tumor cells. This may kill, possiby through antibody-dependent cellular cytotoxicity (ADCC) or other responses, CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:SCTC 21C
SCTC-21C
SCTC21C
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search